Literature DB >> 17941281

Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.

Hideaki Shirasaki1, Nobuhiko Seki, Manabu Fujita, Megumi Kikuchi, Etsuko Kanaizumi, Kazumasa Watanabe, Tetsuo Himi.   

Abstract

BACKGROUND: The cysteinyl leukotrienes (CysLTs) are lipid mediators that have been implicated in the pathogenesis of allergic diseases, and their actions are mediated via specific receptors named CysLT1 receptor (CysLT1R) and CysLT2 receptor (CysLT2R). Little information is known about the role of T(H)2 cytokines in the regulation of both CysLT1R and CysLT2R expression.
OBJECTIVE: To investigate the possible modulation of both CysLT1R and CysLT2R messenger RNA (mRNA) expression, we have developed a real-time quantitative reverse transcription-polymerase chain reaction (RT-PCR) assay based on the TaqMan fluorescence method to quantify CysLT1R and CysLT2R mRNA in human monocytes.
METHODS: Human monocytes were stimulated with leukotriene D4 or interleukin (IL) 4 or IL-13, and the levels of CysLT1R and CysLT2R mRNA were measured by the quantitative RT-PCR.
RESULTS: CysLT1R and CysLT2R mRNA was increased after stimulation with leukotriene D4. CysLT1R mRNA was augmented 150-fold after treatment with IL-4; however, no significant increase was observed in CysLT2R mRNA level. IL-13 could induce a biphasic augmentation of CysLT1R mRNA level. In contrast to IL-4, IL-13 enhanced CysLT2R mRNA level, with a maximal effect at 2 hours of incubation.
CONCLUSIONS: CysLT1R and CysLT2R expression can be regulated by CysLT itself and T(H)2 cytokines at the transcriptional level.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17941281     DOI: 10.1016/S1081-1206(10)60550-9

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  6 in total

1.  IL-2-controlled expression of multiple T cell trafficking genes and Th2 cytokines in the regulatory T cell-deficient scurfy mice: implication to multiorgan inflammation and control of skin and lung inflammation.

Authors:  Rahul Sharma; Poonam R Sharma; Young-Chul Kim; Norbert Leitinger; Jae K Lee; Shu Man Fu; Shyr-Te Ju
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

2.  Regulation of cysteinyl leukotriene receptor 2 expression--a potential anti-tumor mechanism.

Authors:  Cecilia Magnusson; Astrid M Bengtsson; Minghui Liu; Jian Liu; Yvonne Ceder; Roy Ehrnström; Anita Sjölander
Journal:  PLoS One       Date:  2011-12-15       Impact factor: 3.240

3.  The cysteinyl leukotriene 2 receptor contributes to all-trans retinoic acid-induced differentiation of colon cancer cells.

Authors:  Astrid M Bengtsson; Gunilla Jönsson; Cecilia Magnusson; Tavga Salim; Cecilia Axelsson; Anita Sjölander
Journal:  BMC Cancer       Date:  2013-07-08       Impact factor: 4.430

Review 4.  Pharmacotherapy in the management of asthma in the elderly: a review of clinical studies.

Authors:  Mi-Yeong Kim; Woo-Jung Song; Sang-Heon Cho
Journal:  Asia Pac Allergy       Date:  2016-01-27

Review 5.  Cysteinyl leukotrienes and their receptors; emerging concepts.

Authors:  Yoshihide Kanaoka; Joshua A Boyce
Journal:  Allergy Asthma Immunol Res       Date:  2014-05-27       Impact factor: 5.764

Review 6.  A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action.

Authors:  Roger G Biringer
Journal:  J Cell Commun Signal       Date:  2021-06-26       Impact factor: 5.782

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.